E-LIB Suche - Ergebnisse für: Hochster, H.S.

1

Survival Outcomes of Patients With Borderline Resectable an..:

Neibart, S.S. ; Mamidanna, S. ; Chundury, A....
International Journal of Radiation Oncology*Biology*Physics. 111 (2021) 3 - p. e64 , 2021

Link: https://doi.org/10.1016/..

2

Comparing Acute Toxicities of Patients With Unresectable He..:

Mamidanna, S. ; Neibart, S.S. ; Chundury, A....
International Journal of Radiation Oncology*Biology*Physics. 111 (2021) 3 - p. e57 , 2021

Link: https://doi.org/10.1016/..

3

Survival Outcomes of Patients With Unresectable Hepatocellu..:

Mamidanna, S. ; Neibart, S.S. ; Chundury, A....
International Journal of Radiation Oncology*Biology*Physics. 111 (2021) 3 - p. e56-e57 , 2021

Link: https://doi.org/10.1016/..

4

Neutropenia and survival outcomes in metastatic colorectal ..:

Yoshino, T. ; Cleary, J.M. ; Van Cutsem, E....
Annals of Oncology. 31 (2020) 1 - p. 88-95 , 2020

Link: https://doi.org/10.1016/..

5

Interim results from the phase I study of nivolumab (nivo) ..:

Wainberg, Z.A. ; George, B. ; Goldman, J.W....
European Journal of Cancer. 69 (2016) - p. S103 , 2016

Link: https://doi.org/10.1016/..

6

Initial results from a phase 1a/b study of OMP-131R10, a fi..:

Bendell, J. ; Eckhardt, G.S. ; Hochster, H.S....
European Journal of Cancer. 69 (2016) - p. S29-S30 , 2016

Link: https://doi.org/10.1016/..

7

The Bipartisan Colon:

Hochster, H. S.
JNCI Journal of the National Cancer Institute. 107 (2015) 3 - p. djv011-djv011 , 2015

Link: https://doi.org/10.1093/..

8

Erratum to: Phase II study of selumetinib (AZD6244, ARRY-14..:

Hochster, H. S. ; Uboha, N. ; Messersmith, W....
Cancer Chemotherapy and Pharmacology. 75 (2014) 1 - p. 25-25 , 2014

Link: https://doi.org/10.1007/..

9

Phase II study of selumetinib (AZD6244, ARRY-142886) plus i..:

Hochster, H. S. ; Uboha, N. ; Messersmith, W....
Cancer Chemotherapy and Pharmacology. 75 (2014) 1 - p. 17-23 , 2014

Link: https://doi.org/10.1007/..

10

A Phase I Trial of Oral Ridaforolimus (AP23573; MK-8669) in..:

Nemunaitis, J. ; Hochster, H.S. ; Lustgarten, S....
Clinical Oncology. 25 (2013) 6 - p. 336-342 , 2013

Link: https://doi.org/10.1016/..

11

Eyelash Trichomegaly Secondary to Panitumumab Therapy:

Morris, Luc G.T. ; Hochster, H.S. ; DeLacure, M.D.
Current Oncology. 18 (2011) 3 - p. 145-146 , 2011

Link: https://doi.org/10.3747/..

12

1256 Phase I trial of oral Deforolimus in combination with ..:

Nemunaitis, J. ; Hochster, H.S. ; Lustgarten, S....
European Journal of Cancer Supplements. 7 (2009) 2 - p. 137 , 2009

Link: https://doi.org/10.1016/..

13

31P Effect of fruquintinib in patients with heavily pretrea..:

Tabernero, J. ; Eng, C. ; Lonardi, S....
Annals of Oncology. 35 (2024) - p. S15-S16 , 2024

Link: https://doi.org/10.1016/..

14

Atezolizumab with or without bevacizumab in unresectable he..:

Lee, Michael S ; Ryoo, Baek-Yeol ; Hsu, Chih-Hung...
The Lancet Oncology. 21 (2020) 6 - p. 808-820 , 2020

Link: https://doi.org/10.1016/..

15

A phase I and pharmacokinetic study of oxaliplatin and bort..:

Kobrinsky, B. ; Joseph, S. O. ; Muggia, F....
Cancer Chemotherapy and Pharmacology. 72 (2013) 5 - p. 1073-1078 , 2013

Link: https://doi.org/10.1007/..